K. Meyer

Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.

L. Danziger, E. Wenzler, A. Harrington, 2019, International journal of antimicrobial agents.

Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.

E. Wenzler, R. Shields, J. Borjan, 2019, International journal of antimicrobial agents.

Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms

R. Humphries, E. Wenzler, C. Clancy, 2018, The Journal of antimicrobial chemotherapy.

OP-JANM180484 633..638

R. Humphries, E. Wenzler, C. Clancy, 2019 .

Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values

E. Wenzler, Tiffany Wu, M. Biagi, 2022, Microbiology spectrum.

In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient

G. Reid, E. Wenzler, A. Harrington, 2020, Open forum infectious diseases.

Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water

L. Danziger, E. Wenzler, Maressa Santarossa, 2017, Hospital pharmacy.

Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

E. Wenzler, R. Mendes, M. Biagi, 2019, Journal of Clinical Microbiology.